Venous thromboembolism: Racial and ethnic influences

Therapy

Volumn 5, Issue 2, 2008, Pages 169-175

  Patel, Raj K ^a   Arya, Roopen ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Deep vein thrombosis; Ethnicity; Pulmonary embolism; Race; Thrombophilia; Thromboprophylaxis

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S;

AFRICAN AMERICAN; ASIAN; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; EUROPE; FAMILY HISTORY; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; JOINT SURGERY; LUNG EMBOLISM; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RACE DIFFERENCE; RECURRENCE RISK; REFERENCE VALUE; REVIEW; RISK FACTOR; SEX DIFFERENCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 41949084376     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.5.2.169     Document Type: Review

References (74)

1. Sankar P, Cho MK: Genetics: toward a new vocabulary of human genetic variation. Science 298, 1337-1338 (2006).
2. Keenan C, Whitw RH: The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr. Opin. Pulm. Med. 13, 377-383 (2007).
3. Risch N, Burchard E, Ziv E et al.: Categorisation of humans in biomedical research: genes, race and disease. Genome Biol. 3(7), 1-12 (2002).
4. Bowcock AM, Kidd JR, Mountain JL et al.: Drift, admixture, and selection in human evolution: a study with DNA polymorphisms. Proc. Natl Acad. Sci. USA 88, 839-843 (1991).
5. Burchard EG, Ziv E, Coyle N et al.: The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med. 348, 1170-1175 (2003).
6. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al.: Geography of HFE C282Y and H63D mutations. Genet. Test. 4, 183-198 (2000).
7. Yamazaki K, Takazoe M, Tanaka T et al.: Absence of mutation in the NOD3/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 47, 469-472 (2002).
8. Farrer LA, Cupples LA, Haines JL et al.: Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis, JAMA 278, 1349-1356 (1997).
9. Yu MC, Skipper PL, Taghizadeh K et al.: Acetylator phenotype, aminobiphenylhaemoglobin adduct levels, and bladder cancer risk in white, black and Asian men in Los Angeles, California. J. Natl Cancer Inst. 86, 712-716 (1994).
10. Carson P, Ziesche S, Johnson G et al.: Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. J. Card. Fail. 5, 178-187 (1999).
11. Exner DV, Dries DL, Domanski MJ et al.: Lesser response to angiotensin-convertingenzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N. Engl. J. Med. 344, 1351-1357 (2001).
12. Rees DC, Chapman NH, Webster MT et al.: Born to clot: the European burden, Br. J. Haematol. 105(2), 564-566 (1999).
13. Rees DC, Cox M, Clegg JB: World distribution of FV Leiden. Lancet 346, 1133-1134 (1995).
14. Hirst AE, Gore I, Tanaka K et al.: Myocardial infarction and pulmonary embolism. Arch. Pathol. 80, 365-870 (1965).
15. White RH, Zhou H, Romano PS: Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann. Intern. Med. 128, 737-740 (1998).
16. Klatsky AL, Armstrong MA, Poggi J: Risk of pulmonary embolism and/or deep vein thrombosis in Asian-Americans. Am. J. Cardiol. 85, 1334-1337 (2000).
17. Rosenzweig T. Post-operative deep vein thrombosis is infrequent in Alaska Natives. Int. J. Circumpolar Health 62(4), 388-396 (2003).
18. Stein PD, Kayali F, Olson RE et al.: Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am. J. Med. 116(7), 435-442 (2004).
19. Nossent JC, Egelie NCWM: Incidence and course of symptomatic deep vein thrombosis of the lower extremites in a black-Caribbean population. Thromb. Haemost. 70(4), 576-578 (1993).
20. Thomas WA, Davies JN, O'Neal RM et al.: Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St. Louis, USA. Am. J. Cardiol. 5, 41-47 (1960).
21. Hassan MA, Rahman EA, Rahan IA: Postoperative deep vein thrombosis in Sudanese patients. BMJ 1, 515-517 (1973).
22. Cunningham IGE, Yonk NK: The incidence of postoperative deep venous thrombosis in Malaysia. Br. J. Surg. 61, 482-483 (1974).
23. Patel RK, Ford E, Thumpston J et al.: Risk factors for venous thrombosis in the black population. Thromb. Haemost. 90(5), 835-839 (2003).
24. White RH: The epidemiology of venous thromboembolism. Circulation 107, 14-18 (2003).
25. White RH, Dager WE, Zhou H et al.: Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb. Haemost. 96, 267-273 (2006).
26. Hankey G, Eikelboom JW: Routine thrombophilia testing in stroke patients is unjustified. Stroke 34, 1826-1827 (2003).
27. Koster T, Rosendaal FR, Reitsma PH et al.: Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms. The Leiden Thrombophilia Study (LETS). Thromb. Haemost. 71(6), 719-722 (1994).
28. Rosendaal FR, Koster T, Vandenbroucke JP et al.. High risk of thrombosis in patients homozygous for FV Leiden (activated protein C resistance). Blood 85, 1504-1508 (1995).
29. Ferraresi P, Marchetti G, Legnani C et al.: The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler. Thromb. Vasc. Biol. 17, 2418 (1997).
30. Nakamura M, Fujioka H, Yamada N et al.: Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicentre registry in the Japanese Society of Pulmonary Embolism Research. Clin. Cardiol. 24, 132-138 (2001).
31. Silverstein MD, Heit JA, Mohr DN et al.: Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch. Int. Med. 158(6), 585-593 (1998).
32. White RH, Zhou H, Romano PS: Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann. Intern. Med. 128, 737-740 (1998).
33. White RH, Zhou H, Gage BF: Effect of age on the incidence of venous thromboembolism after major surgery. J. Thromb. Haemost. 2, 1327-1333 (2004).
34. White RH, Zhou H, Murin S et al.: Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb. Haemost. 93, 298-305 (2005).
35. Stein PD, Huang H, Afzal A et al.: Incidence of acute pulmonary embolism in a general hospital. Relation to age, sex, and race. Chest 116, 909-913 (1999).
36. Stein PD, Hull RD, Patel KC et al.: Venous thromboembolic disease. Comparison of the diagnostic process in blacks and whites. Arch. Int. Med. 163, 1843-1848 (2003).
37. Siddique RM, Siddique MI, Connors AF Jr et al.: Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch. Int. Med. 156, 2343-2347 (1996).
38. Stein PD, Kayali F, Olson RE: Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am. J Cardiol. 93, 1197-1199 (2004).
39. Schneider D, Lilienfield DE, Im W: The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J. Natl Med. Assoc. 98, 1967-1972 (2006).
40. Aujesky D, Long JA, Fine MJ et al.: African-American race was associated with an increased risk of complications following venous thromboembolism. J. Clin. Epidemiol. 60 (940), 410-416 (2006).
41. Dowling NF, Austin H, Dilley A et al.: The epidemiology of venous thromboembolism in Caucasians and Afro-Americans: the GATE Study. J. Thromb. Haemost. 1, 80-87 (2003).
42. Atichartakarn V, Pathepchotiwong K, Keorochana S et al.: Deep vein thrombosis after hip surgery among Thai. Arch. Intern. Med. 148, 1349-1353 (1988).
43. Cheuk BL, Cheung GC, Cheng SW: Epidemiology of venous thromboembolism in a Chinese population. Br. J. Surg. 91(4), 424-428 (2004).
44. Bagaria V, Modi N, Panghate A et al.: Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study Postgrad. Med. J. 82(964), 136-139 (2006).
45. Hirst AE, Gore I, Tanaka K et al.: Myocardial infarction and pulmonary embolism. Arch. Pathol. 80(4), 365-370 (1965).
46. Dhillon KS, Askander A, Doraismay S: Postoperative deep vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis. J Bone Joint Surg Br. 78, 427-430 (1996).
47. Piovella F, Wang CJ, Lu H, et al.: Deep-vein thrombosis rates after major orthopaedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J. Thromb. Haemost. 3(12), 2664-2770 (2005).
48. Mok CK, Hoaglund FT, Rogoff SM et al.: The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur. Br. J. Surg. 66, 640-642 (1979).
49. Leizorovvicz A, Turpie AG, Cohen AT et al.: Epidemiology of venous thremboembolism in Asian patients undergoing major orthopaedic surgery withour thromboprophlaxis. The SMART study. J. Thromb. Haemost. 3(1), 28-34 (2005).
50. Sakon M, Maehara Y. Yoshikawa H et al.: Incidence of venous thromboembolism following major abdominal surgery: a multicentre, prospective epidemiological study in Japan. J. Thromb. Haemost. 4, 581-586 (2006).
51. Chan LY, Tam WH, Lau TK: Venous thromboembolism in pregnant Chinese women. Obstet. Gynenol. 98(3), 471-475 (2001).
52. Chan LY, Yuen PM, Lau TK: Symptomatic venous thromboembolism in Chinese patients after gynaecological surgery: incidence and disease pattern. Acta. Obstet. Gynecol. Scand. 81(4), 343-3416 (2002).
53. Lee AC, Li CH, Szeto SC et al.: Symptomatic venous thromboembotism in Hong Kong Chinese children. Hong Kong Med, J. 9(4), 259-262 (2003).
54. de Silva DA, Pey HB, Wong MC et al.: Deep vein thrombosis following Ischaemic stroke among Asians. Cerebrovasc. Dis. 22(4), 2457250 (2006).
55. Yoo MC, Kang YH, Kim YH et al.: A prospective randomised study on the use of nadroparin calciumin the prophylxis of Korean patients undergoing elective total hip replacement. Int. Orthop. 21(6), 399-402 (1997).
56. Fong YK, Ruban P, Yeo SJ et al.: Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty - a study of its efficacy in Asian patients. Ann. Acad. Med Singap. 29(4), 439-441 (2000).
57. Kryle PA, Minar E, Bialonczyk C et al.: The risk of recurrent venous thromboembolism in men and women. N. Eng. J. Med. 350, 2558-2563 (2004).
58. Eriksson H, Lundstrom T, Wahlander C et al.: Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran. Thromb. Haemost. 94, 522-527 (2005).
59. van Hylckama Vlieg A, Baglin CA, Baglin TP: Is there a true difference in recurrence rate of deep vein thrombosis between men and women? J. thromb Haemost. 3, 2113-2114 (2005).
60. Pepe G, Rickards O, Venegas OC et al.: Prevalence of factor V Leiden mutation in non-European populations. Thromb. Haemost. 78(2), 961-962 (1997).
61. Garewal G, Das R, Varma S et al.: Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism. J. Thromb. Haemost. 1(6), 1329 (2003).
62. Ridker PM, Miletich JP, Hennekens CH et al.: Ethnic distribution of factor V Leiden in 4047 men and women: implication for venous thromboembolism screening. JAMA 277, 1305-1307 (1997).
63. Franco RF, Santos, SE, Elion J et al.: Prevalence of the G20210A polymorphism in the 3′ untranslated region of the prothrombin gene in different human populations. Acta Haematol. 100(1), 9-12 (1998).
64. Folsom AR, Wu KK, Davis CE: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 9l, 191-205 (1991).
65. Folsom AR, Qamhieh HT, Flack JM et al.: Plasma fibrinogen: levels and correlates in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am. J. Epidemiol. 138, 1023-1036 (1993).
66. Austin H, Hooper WC, Lally C et al.: Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J. Clin. Epidem. 53 (10). 997-1001 (2000).
67. Cook DG, Cappuccio FP. Atkinson RW et al.: Ethnic differences in fibrinogen levels: the role of environmental factors and the β-fibrinogen gene. Am. J. Epidemiol. 153 (8), 799-806 (2001).
68. Fang J, Madhavan S, Alderman MH: The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N. Engl, J. Med. 335, 1545-1551 (1996).
69. Balarajan R: Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 302, 560-564 (1991).
70. Capuccoio FP, Cook DG, Atkinson R et al.: Prevalence, detection and management of cardiovascular risk factors in different ethnic groups in south London. Heart 78, 555-563 (1997).
71. Capuccoio FF, Cook DG, Atkinson R et al.: The Wandsworth Heart and Stroke Study: a population based survey of cardiovascular risk factors in different ethnic groups. Nutr. Metab. Cardiovasc. Dis. 8, 371-385 (1998).
72. Metcalfe PA, Sharrett AR, Folsom AR et al.: African-American-White differences in lipids, lipopiciteins and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 148, 750-760 (1998).
73. Jerrard-Dunne P, Evans A, McGovern R et al.: Ethnic differences in markers of thrombophilia. Implications for the investigation of ischaemic stroke in multiethnic populations: The South London Ethnicity and Stroke Study. Stroke 34, 1821-1827 (2003).
74. Patel RK, Arya R: Tests for hereditary thrombophilia are of limited value in the black population. Stroke 34 (12), 236 (2003).